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STELLINGEN
behorende bij het proefschrift
INTRAMYOCARDIAL BONE MARROW CELL 
INJECTION: CLINICAL AND FUNCTIONAL 
EFFECTS IN ISCHEMIC HEART DISEASE
1.  It is an unfortunate irony that the prolongation of life due to the improvement of 
cardiovascular care and treatment is responsible for an increase in the number 
of patients with end-stage ischemic coronary disease, some who complain from 
intractable episodes of angina. ESC guidelines on the management of stable angina 
pectoris, 2006
2.  Intramyocardial injection of bone marrow-derived mononuclear cells is a safe and 
effective treatment strategy for patients with chronic myocardial ischemia which 
are not eligible for conventional revascularization. (this thesis)
3.  The clinical and functional benefits observed after bone marrow cell injection are 
likely to be related to improved myocardial perfusion, which is resulting from 
enhanced neovascularization. (this thesis)
4.  Until now, intramyocardial bone marrow cell injection is the only adjunctive 
therapy for patients with refractory angina which results in objective improvements 
in myocardial perfusion. (this thesis)
5.  Since the duration of treatment effect is probably determined by the balance 
between the formation of new blood vessels and the progression of underlying 
atherosclerosis, repeat bone marrow cell injection may be effective in selected 
patients. (this thesis)
6.  Lack of differentiation and fusion should not be considered a weakness of bone 
marrow-derived cells therapy if angina, ischemia, and left ventricular function are 
improved by the therapy, however. E. Kevin Heist, Heart Rhythm, 2008
7.  Comparative studies providing information on the optimal conditions for cardiac 
cell therapy are of crucial importance for future clinical research. (this thesis)
8.  The field of cardiac cell therapy is in its relative infancy and the use of different cell 
types, guided development, and a better understanding of mechanistic concepts 
may yet bear fruit. Bernard J. Gersh, Mayo Clinic Proceedings, 2009
9.  Clinical trials relate to clinical practice as Muzak to Mozart
 Anthony N. DeMaria, 28th Einthoven lecture, 2008
10.  High health care costs should also be considered as an expression of wealth and 
civilization.
11.  Without deviation from the norm, progress is not possible. 
 Frank Zappa, Television interview (VPRO), 1971
12.  It’s not the notes you play, it’s the notes you don’t play.
 Old jazz adage 
Jan van Ramshorst
